| Katherine Irene Warner, DO | |
|
1607 Creekside Loop, Yakima, WA 98902-4882 | |
| (509) 453-4614 | |
| (509) 225-2712 |
| Full Name | Katherine Irene Warner |
|---|---|
| Gender | Female |
| Speciality | Vascular Surgery |
| Experience | 14 Years |
| Location | 1607 Creekside Loop, Yakima, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003137506 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| North Colorado Medical Center | Greeley, CO | Hospital |
| Virginia Mason Memorial | Yakima, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Community Vascular Washington Pllc | 8123498169 | 3 |
| Banner Health Physicians Colorado Llc | 8921273038 | 245 |
News Archive
A new study from Rhode Island Hospital now sheds light on both the quantity of MRSA at different body sites and the relationship between the quantities at different sites.
Protalix BioTherapeutics, Inc., announced today that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) regarding the Company's New Drug Application (NDA) for taliglucerase alfa for the treatment of Gaucher disease. Taliglucerase alfa is a plant-cell expressed form of glucocerebrosidase (GCD).
We know from earlier studies that mice can derive genetic benefits when females mate with multiple males, but until recently, the conditions under which females will voluntarily mate with multiple males were not clear. Kerstin Thonhauser and her colleagues from the Konrad Lorenz Institute of Ethology of the Vetmeduni Vienna conducted a series of experiments in which female wild-derived house mice (Mus musculus) could mate freely with one or two males while not in danger of sexual coercion by a male.
VWR, a leading, global, independent provider of laboratory products, services and solutions, announced today that it has acquired Purification Technologies Inc., a specialty solvent company that performs high volume purification of selected high purity solvents. This acquisition will enhance VWR's growing laboratory and production chemical manufacturing portfolio to better support its laboratory and biopharmaceutical manufacturing customers.
Proposals to extend payroll tax relief, as well as take steps to prevent a scheduled 30 percent reduction in Medicare physician reimbursements from taking effect in January, are high on the congressional to-do list. A House vote on a doc-fix patch could take place as soon as next week.
› Verified 2 days ago
| Entity Name | Multicare Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497766638 PECOS PAC ID: 7719899897 Enrollment ID: O20031105000760 |
News Archive
A new study from Rhode Island Hospital now sheds light on both the quantity of MRSA at different body sites and the relationship between the quantities at different sites.
Protalix BioTherapeutics, Inc., announced today that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) regarding the Company's New Drug Application (NDA) for taliglucerase alfa for the treatment of Gaucher disease. Taliglucerase alfa is a plant-cell expressed form of glucocerebrosidase (GCD).
We know from earlier studies that mice can derive genetic benefits when females mate with multiple males, but until recently, the conditions under which females will voluntarily mate with multiple males were not clear. Kerstin Thonhauser and her colleagues from the Konrad Lorenz Institute of Ethology of the Vetmeduni Vienna conducted a series of experiments in which female wild-derived house mice (Mus musculus) could mate freely with one or two males while not in danger of sexual coercion by a male.
VWR, a leading, global, independent provider of laboratory products, services and solutions, announced today that it has acquired Purification Technologies Inc., a specialty solvent company that performs high volume purification of selected high purity solvents. This acquisition will enhance VWR's growing laboratory and production chemical manufacturing portfolio to better support its laboratory and biopharmaceutical manufacturing customers.
Proposals to extend payroll tax relief, as well as take steps to prevent a scheduled 30 percent reduction in Medicare physician reimbursements from taking effect in January, are high on the congressional to-do list. A House vote on a doc-fix patch could take place as soon as next week.
› Verified 2 days ago
| Entity Name | King County Public Hospital District No 2 |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801986070 PECOS PAC ID: 7618880097 Enrollment ID: O20031111000557 |
News Archive
A new study from Rhode Island Hospital now sheds light on both the quantity of MRSA at different body sites and the relationship between the quantities at different sites.
Protalix BioTherapeutics, Inc., announced today that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) regarding the Company's New Drug Application (NDA) for taliglucerase alfa for the treatment of Gaucher disease. Taliglucerase alfa is a plant-cell expressed form of glucocerebrosidase (GCD).
We know from earlier studies that mice can derive genetic benefits when females mate with multiple males, but until recently, the conditions under which females will voluntarily mate with multiple males were not clear. Kerstin Thonhauser and her colleagues from the Konrad Lorenz Institute of Ethology of the Vetmeduni Vienna conducted a series of experiments in which female wild-derived house mice (Mus musculus) could mate freely with one or two males while not in danger of sexual coercion by a male.
VWR, a leading, global, independent provider of laboratory products, services and solutions, announced today that it has acquired Purification Technologies Inc., a specialty solvent company that performs high volume purification of selected high purity solvents. This acquisition will enhance VWR's growing laboratory and production chemical manufacturing portfolio to better support its laboratory and biopharmaceutical manufacturing customers.
Proposals to extend payroll tax relief, as well as take steps to prevent a scheduled 30 percent reduction in Medicare physician reimbursements from taking effect in January, are high on the congressional to-do list. A House vote on a doc-fix patch could take place as soon as next week.
› Verified 2 days ago
| Entity Name | Memorial Physicians Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962938183 PECOS PAC ID: 4789733494 Enrollment ID: O20100602000561 |
News Archive
A new study from Rhode Island Hospital now sheds light on both the quantity of MRSA at different body sites and the relationship between the quantities at different sites.
Protalix BioTherapeutics, Inc., announced today that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) regarding the Company's New Drug Application (NDA) for taliglucerase alfa for the treatment of Gaucher disease. Taliglucerase alfa is a plant-cell expressed form of glucocerebrosidase (GCD).
We know from earlier studies that mice can derive genetic benefits when females mate with multiple males, but until recently, the conditions under which females will voluntarily mate with multiple males were not clear. Kerstin Thonhauser and her colleagues from the Konrad Lorenz Institute of Ethology of the Vetmeduni Vienna conducted a series of experiments in which female wild-derived house mice (Mus musculus) could mate freely with one or two males while not in danger of sexual coercion by a male.
VWR, a leading, global, independent provider of laboratory products, services and solutions, announced today that it has acquired Purification Technologies Inc., a specialty solvent company that performs high volume purification of selected high purity solvents. This acquisition will enhance VWR's growing laboratory and production chemical manufacturing portfolio to better support its laboratory and biopharmaceutical manufacturing customers.
Proposals to extend payroll tax relief, as well as take steps to prevent a scheduled 30 percent reduction in Medicare physician reimbursements from taking effect in January, are high on the congressional to-do list. A House vote on a doc-fix patch could take place as soon as next week.
› Verified 2 days ago
| Entity Name | Community Vascular Washington Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710603907 PECOS PAC ID: 8123498169 Enrollment ID: O20230109000090 |
News Archive
A new study from Rhode Island Hospital now sheds light on both the quantity of MRSA at different body sites and the relationship between the quantities at different sites.
Protalix BioTherapeutics, Inc., announced today that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) regarding the Company's New Drug Application (NDA) for taliglucerase alfa for the treatment of Gaucher disease. Taliglucerase alfa is a plant-cell expressed form of glucocerebrosidase (GCD).
We know from earlier studies that mice can derive genetic benefits when females mate with multiple males, but until recently, the conditions under which females will voluntarily mate with multiple males were not clear. Kerstin Thonhauser and her colleagues from the Konrad Lorenz Institute of Ethology of the Vetmeduni Vienna conducted a series of experiments in which female wild-derived house mice (Mus musculus) could mate freely with one or two males while not in danger of sexual coercion by a male.
VWR, a leading, global, independent provider of laboratory products, services and solutions, announced today that it has acquired Purification Technologies Inc., a specialty solvent company that performs high volume purification of selected high purity solvents. This acquisition will enhance VWR's growing laboratory and production chemical manufacturing portfolio to better support its laboratory and biopharmaceutical manufacturing customers.
Proposals to extend payroll tax relief, as well as take steps to prevent a scheduled 30 percent reduction in Medicare physician reimbursements from taking effect in January, are high on the congressional to-do list. A House vote on a doc-fix patch could take place as soon as next week.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Katherine Irene Warner, DO 3800 Summitview Ave, Yakima, WA 98902 Ph: (509) 248-7849 | Katherine Irene Warner, DO 1607 Creekside Loop, Yakima, WA 98902-4882 Ph: (509) 453-4614 |
News Archive
A new study from Rhode Island Hospital now sheds light on both the quantity of MRSA at different body sites and the relationship between the quantities at different sites.
Protalix BioTherapeutics, Inc., announced today that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) regarding the Company's New Drug Application (NDA) for taliglucerase alfa for the treatment of Gaucher disease. Taliglucerase alfa is a plant-cell expressed form of glucocerebrosidase (GCD).
We know from earlier studies that mice can derive genetic benefits when females mate with multiple males, but until recently, the conditions under which females will voluntarily mate with multiple males were not clear. Kerstin Thonhauser and her colleagues from the Konrad Lorenz Institute of Ethology of the Vetmeduni Vienna conducted a series of experiments in which female wild-derived house mice (Mus musculus) could mate freely with one or two males while not in danger of sexual coercion by a male.
VWR, a leading, global, independent provider of laboratory products, services and solutions, announced today that it has acquired Purification Technologies Inc., a specialty solvent company that performs high volume purification of selected high purity solvents. This acquisition will enhance VWR's growing laboratory and production chemical manufacturing portfolio to better support its laboratory and biopharmaceutical manufacturing customers.
Proposals to extend payroll tax relief, as well as take steps to prevent a scheduled 30 percent reduction in Medicare physician reimbursements from taking effect in January, are high on the congressional to-do list. A House vote on a doc-fix patch could take place as soon as next week.
› Verified 2 days ago
Justin A Robinson, MD Surgery Medicare: Medicare Enrolled Practice Location: 3999 Englewood Ave, Suite 202, Yakima, WA 98902 Phone: 509-453-4614 Fax: 509-453-3468 | |
Lorena P De Marco Garcia, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1607 Creekside Loop, Suite 100, Yakima, WA 98902 Phone: 509-453-4614 Fax: 509-225-2712 | |
Jihui Li, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 3003 Tieton Dr Ste 300, Yakima, WA 98902 Phone: 509-575-3946 | |
Dr. Peter R Young Jr., M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 3003 Tieton Dr, Suite 300, Yakima, WA 98902 Phone: 509-575-3946 Fax: 509-225-6449 | |
Dr. Amber Nicole Wooten, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 3003 Tieton Dr Ste 300, Yakima, WA 98902 Phone: 509-575-3946 Fax: 509-225-2701 | |
Lester Shinchen Young, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2811 Tieton Dr, Yakima, WA 98902 Phone: 509-575-3946 |